The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
Combining genetic tests may better define complex SMN gene changes in SMA, including SMN2 copy numbers and hybrid structures.
Asianet Newsable on MSN
Delhi water crisis: Typhoid, diarrhoea cases rise in Gulmohar Park
Residents of South Delhi's Gulmohar Park are facing a health crisis with a surge in typhoid, diarrhoea, and other water-borne ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Commercialization Timeline -- TB test expected to reach commercial deployment in India by third quarter of 2026.
Minaris has expanded its rapid mycoplasma testing capability through the implementation of bioMérieux’s BIOFIRE Mycoplasma ...
Seegene, a global molecular diagnostics company, announced the European launch of its new antimicrobial resistance (AMR) ...
Q1 2026 Management View "This continues to be an active and important period for our business as we execute on the opportunities ahead and remain focused on positioning the company for its next phase ...
At this year’s American Society of Human Genetics annual meeting, Technology Networks caught up with Dr. Chelsea Pratt, biopharma segment manager at Bio-Rad Laboratories, who was exploring advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results